乳腺癌
聚合酶
核糖
化学
新陈代谢
癌症
分子生物学
生物化学
医学
酶
生物
内科学
作者
Anthony J. Young,Austin R. Pantel,Mahsa Kiani,Robert K. Doot,Sina Bagheri,Daniel A. Pryma,Michael D. Farwell,Shihong Li,Hsiaoju Lee,Erin K. Schubert,Anthony Secreto,Samantha P. Zuckerman,Anupma Nayak,Hoon Choi,Sean Carlin,Angela DeMichele,David A. Mankoff,Rong Zhou,Robert H. Mach,Elizabeth S. McDonald
标识
DOI:10.2967/jnumed.124.268254
摘要
The poly(adenosine diphosphate-ribose) polymerase inhibitors (PARPi) have demonstrated efficacy in ovarian, breast, and prostate cancers, but current biomarkers do not consistently predict clinical benefit.
科研通智能强力驱动
Strongly Powered by AbleSci AI